Slide 1: Welcome to the Q3 2021 Financial Results Webcast
1 Welcome to the Q3 2021 Financial Results Webcast NNIT A/S November 3 1
Slide 2: Representing NNIT A/S today
Representing NNIT A/S today Pär Fors Pernille Fabricius Chief Executive Officer Chief Financial Officer 2
Slide 3: Agenda
Agenda 01 Highlights for Q3 2021 02 Financial performance 03 Balance sheet and cash flow 04 Outlook for 2021 05 Closing remarks 3
Slide 4: Forward-looking statements
Forward-looking statements This announcement contains forward-looking statements. Words such as ‘believe’, ‘expect’, ‘may’, ‘will’, ‘plan’, ‘strategy’, ‘prospect’, ‘foresee’, ‘estimate’, ‘project’, ‘anticipate’, ‘can’, ‘intend’, ‘outlook’, ‘guidance’, ‘target’ and other words and terms of similar me
Slide 5: Agenda
Agenda 01 Highlights for Q3 2021 02 Financial performance 03 Balance sheet and cash flow 04 Outlook for 2021 05 Closing remarks 5
Slide 6: NNIT's revenue increased by 6.1%, but…
NNIT’s revenue increased by 6.1 %, but… We are actively working on Focusing on international growth executing on our strategy and our Winning Solutions 6
Slide 7: Business Highlights
Business Highlights Winning Solutions NNIT acquired SL is now at 54% of Controls on July 5 total revenue NNIT secured a large The process of gathering number of smaller all infrastructure contracts activities is ongoing 7
Slide 8: Another M&A milestone with SL Controls
Another M&A milestone with SL Controls Looking to acquire more to We have acquired yet another further strengthen The NNIT international IT company Group’s position 8
Slide 9: We are optimistic that we can solve the challenges we have identified in our business
We are optimistic that we can solve the challenges we have identified in our business We are adjusting our cost base, Our pipeline contains more of the optimizing our global delivery projects and contracts we want model and increasing automation 9
Slide 10: Agenda
Agenda 01 Highlights for Q3 2021 02 Financial performance 03 Balance sheet and cash flow 04 Outlook for 2021 05 Closing remarks 10
Slide 11: Q3 2021 & 9M 2021 at a glance
Q3 2021 & 9M 2021 at a glance Revenue Winning solutions Operating profit* Investment level** DKK 698m DKK 377m DKK 21m DKK 24m Q3 2021 6.1% growth 54% 3.0% 3.4% -1.5% organic growth % of revenue operating profit margin % of revenue Revenue Winning solutions Operating profit* Investment level** DKK 2
Slide 12: Group Performance Overview
Group Performance Overview Q3 2021 9M 2021 FY 2020 DKK million Q3 2021 Q3 2020 Change 9M 2021 9M 2020 Change 2020 Revenue 698 658 6,1% 2.139 2.081 2,8% 2.830 Cost of goods sold 625 578 8,1% 1.880 1.805 4,2% 2.443 Gross profit 73 80 -8,8% 259 276 -6,2% 387 Gross profit margin 10,5% 12,2% -1,7pp 12,1%
Slide 13: Life Sciences
Life Sciences Q3 2021 9M 2021 FY 2020 DKK million Q3 2021 Q3 2020 Change 9M 2021 9M 2020 Change 2020 Life Sciences (excl. NNG) 246 181 35,9% 708 514 37,7% 717 Life Sciences (Int.) 187 122 53,3% 511 320 59,7% 456 Life Sciences (DK) 59 59 0,0% 197 194 1,5% 261 Novo Nordisk Group 142 163 -12,9% 452 523
Slide 14: Private & Public
Private & Public Q3 2021 9M 2021 FY 2020 DKK million Q3 2021 Q3 2020 Change 9M 2021 9M 2020 Change 2020 Enterprise 179 164 9,1% 535 540 -0,9% 712 Public 68 91 -25,3% 241 303 -20,5% 407 Finance 63 59 6,8% 203 201 1,0% 262 Revenue 310 314 -1,3% 979 1.044 -6,2% 1.381 Cost of goods sold 287 286 0,3% 893
Slide 15: Agenda
Agenda 01 Highlights for Q3 2021 02 Financial performance 03 Balance sheet and cash flow 04 Outlook for 2021 05 Closing remarks 15
Slide 16: Balance sheet
Balance sheet Assets Sep 30, Sep 30, Dec 31, Equity and liabilities Sep 30, Sep 30, Dec 31, DKK million 2021 2020 2020 DKK million 2021 2020 2020 Intangible assets 934 519 781 Share capital 250 250 250 Tangible assets 501 558 552 Treasury shares -2 -3 -3 Lease assets 192 245 227 Retained earnings 87
Slide 17: Cash flows
Cash flows Cash flow Dec 31, Q3 2021 Q3 2020 9M 2021 9M 2020 DKK million 2020 Net profit for the period -10 9 -9 58 76 Reversal of non-cash items 88 78 256 282 228 Net interest and taxes paid 1 -12 -26 -43 -58 Changes in working capital -121 -41 -112 50 282 Cash flow from operating activities -42 34
Slide 18: Agenda
Agenda 01 Highlights for Q3 2021 02 Financial performance 03 Balance sheet and cash flow 04 Outlook for 2021 05 Closing remarks 18
Slide 19: Backlog development, current year
Backlog development, current year Backlog for the year, beginning of Q4 2021 +3.7% (+99) • At the beginning of Q4 2021, NNIT’s order entry backlog for 2021 3.000 2,790 2,691 2,643 amounted to DKK 2,790 million, up 3.7% from last year. 2,507 2.500 2,379 • Life Sciences (excl. NNG) customers increased
Slide 20: Outlook
Outlook 2021 Revenue growth Reported currencies: 1-4% Operating profit margin Reported currencies: Around 5% before special items CAPEX Share of revenue: 5-7%1 1CAPEX investments and re- investments are in 2021 expected to be between 5-7 percent of total revenue excluding acquisitions 20
Slide 21: Agenda
Agenda 01 Highlights for Q3 2021 02 Financial performance 03 Balance sheet and cash flow 04 Outlook for 2021 05 Closing remarks 21
Slide 22: Closing remarks
Closing remarks Momentum within Life Sciences Winnings Solutions Expectations for 2021 International continued that now constitute 54% remain, and we maintain the strong growth in Q3 of total revenue our financial guidance 2021 with revenue increasing 36% compared to Q3 2020 Strategy established to
Slide 23: Questions
Questions ANIT
Slide 24: Investor contact information
Investor contact information Financial Calendar Investor contact January 25, 2022 • Deadline for NNIT Shareholders to submit resolutions to be considered by the Annual General Meeting Pernille Fabricius January 28, 2022 • Annual report 2021 March 10, 2022 • Annual General Meeting Chief Financial Off
Slide 25: We make a mark
We make a mark nnit.com ANIT